Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 285-294

  Manavi, M ^a   Hudelist, G ^a   Fink Retter, A ^a   Gschwantler Kaulich, D ^a   Pischinger, K ^a   Czerwenka, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Austria; Cervical carcinoma; Human papillomavirus; Physical state

Indexed keywords

MESSENGER RNA; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ADULT; AGED; ARTICLE; AUSTRIA; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER RISK; DNA SEQUENCE; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DNA CELL DNA INTERACTION;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; AUSTRIA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD; VIRUS INTEGRATION;

EID: 40549135711     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01017.x     Document Type: Article

References (48)

1. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst (Bethesda) 2000 92 : 690 8.
2. Munoz N, Bosch FX, de Sanjose S et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
3. Syrjänen K, Syrjänen S. Epidemiology of genital HPV infections, CIN and cervical cancer. In : Syrjänen K, Syrjänen S, eds. Papilloma virus infections in human pathology, 1st edn. New York, NY : John Wiley, 2000 : 117 42.
4. Meijer CJ, Walboomers JM. Cervical cytology after 2000: where to go? J Clin Pathol 2000 53 : 41 3.
5. Dray M, Russell P, Dalrymple C et al. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005 37 : 112 24.
6. Klaes R, Friedrich T, Spitkovsky D et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001 92 : 276 84.
7. Klaes R, Woerner SM, Ridder R et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999 59 : 6132 6.
8. Luft F, Klaes R, Nees M et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001 92 : 9 17.
9. Manavi M, Czerwenka KF, Enzelsberger H et al. Human papillomavirus (HPV) DNA infections of the uterine cervix. Geburtshilfe Frauenheilkd 1992 52 : 283 6.
10. Harper DM, Franco EL, Wheeler C et al for the GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004 364 : 1757 65.
11. Steinbrook R. The potential of human papillomavirus vaccines. N Engl J Med 2006 354 : 1109 13.
12. Harro CD, Pang YY, Roden BB et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst 2001 93 : 284 92.
13. Schiller JT, Lowy DR. Papillomavirus-like particle based vaccines: cervical cancer and beyond. Expert Opin Biol Ther 2001 1 : 571 81.
14. Syrjänen K, Syrjänen S. Molecular biology of papillomaviruses. In : Syrjänen K, Syrjänen S, eds. Papillomavirus infection in human pathology, 1st edn. New York, NY : John Wiley, 2000 : 11 52.
15. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991 65 : 606 12.
16. Pirami L, Giache V, Becciolini A. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol 1997 50 : 600 4.
17. Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992 73 : 2327 36.
18. Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002 40 : 886 91.
19. Nagao S, Yoshinouchi M, Miyagi Y et al. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol 2002 40 : 863 7.
20. Lehn H, Villa LL, Marziona F, Hilgarth M, Hillemans HG, Sauer G. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol 1988 69 : 187 96.
21. Fukushima M, Yamakawa Y, Shimano S, Hashimoto M, Sawada Y, Fujinaga K. The physical state of human papillomavirus 16 DNA in cervical carcinoma and cervical intraepithelial neoplasia. Cancer 1990 66 : 2155 61.
22. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004 64 : 3878 84.
23. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989 172 : 63 72.
24. Fuchs PG, Girardi F, Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int J Cancer 1989 43 : 41 4.
25. Hudelist G, Manavi M, Pischinger KID et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004 92 : 873 80.
26. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996 22 : 629 36.
27. Cope JU, Hildesheim A, Schiffman MH et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 1997 35 : 2262 5.
28. Venuti A, Marcante ML. Presence of human papillomavirus type 18 DNA in vulvar carcinomas and its integration into the cell genome. J Gen Virol 1989 70 : 1587 92.
29. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000 60 : 396 402.
30. Zehbe I, Hacker GW, Su H, Hauser-Kronberger C, Hainfeld JF, Tubbs R. Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus. Am J Pathol 1997 150 : 1553 61.
31. Lizard G, Demares-Poulet MJ, Roignot P, Gambert P. In situ hybridization detection of single-copy human papilloma on isolated cells, using a catalyzed signal amplification system: GenPoint. Diagn Cytopathol 2001 24 : 112 6.
32. Plummer TB, Sperry AC, Xu HS, Lloyd RV. In situ hybridization detection of low copy nucleic acid sequences using catalyzed reporter deposition and its usefulness in clinical human papillomavirus typing. Diagn Mol Pathol 1998 7 : 76 84.
33. Huang CC, Qui JT, Kashima ML, Kurman RJ, Wu TC. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998 11 : 971 7.
34. Siadat-Pajouh M, Ayscue AH, Periasamy A, Herman B. Introduction of a fast and sensitive fluorescent in situ hybridization method for single-copy detection of human papillomavirus (HPV) genome. J Histochem Cytochem 1994 42 : 1503 12.
35. Callahan DE, Karim A, Zheng G, Ts'o PO, Lesko SA. Quantitation and mapping of integrated human papillomavirus on human metaphase chromosomes using a fluorescence microscope imaging system. Cytometry 1992 13 : 453 61.
36. Cornelissen MT, Smits HL, Briet MA et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol 1990 71 : 1234 46.
37. Swan DC, Tucker RA, Tortolero-Luna G et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999 37 : 1030 4.
38. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995 69 : 2989 97.
39. Park JS, Hwang ES, Park SN et al. Physical status and expression of HPV genomes in cervical cancers. Gynecol Oncol 1997 65 : 121 9.
40. Badaracco G, Venuti A, Sedati A, Marcante ML. HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 2002 67 : 574 82.
41. Vernon SD, Unger ER, Miller DL, Lee DR, Reeves WC. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 1997 74 : 50 6.
42. Evans MF, Cooper K. Human papillomavirus integration: detection by in situ hybridization and potential clinical application. J Pathol 2004 202 : 1 4.
43. Cuschieri KS, Cubie HA, Whitley MW et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004 57 : 68 72.
44. Corona Gutierrez CM, Tinoco A, Navarro T et al. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN1, CIN 2 and CIN3) associated with infection by oncogenic human papillomavirus. Hum Gene Ther 2004 15 : 421 31.
45. Heim K, Hudelist G, Geier A et al. Mutter-Kind-Übertragung von virusneutralisierenden HPV-Antikörpern - ein möglicher Schutz gegen klinische HPV-Erkrankungen des Neugeborenen. Geburtshilfe Frauenheilkd 2006 67 (S1 32.
46. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999 91 : 252 8.
47. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993 12 : 186 92.
48. Solomon D, Schiffman M, Tarone R ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001 93 : 293 9.